Holen Sie sich die Stockscreener-App
131.80
2.15%
2.78
Vorhandelsmarkt:
131.30
-0.50
-0.38%
Schlusskurs vom Vortag:
$129.02
Offen:
$128.93
24-Stunden-Volumen:
633.63K
Relative Volume:
0.86
Marktkapitalisierung:
$7.99B
Einnahmen:
$3.99B
Nettoeinkommen (Verlust:
$463.16M
KGV:
18.56
EPS:
7.1
Netto-Cashflow:
$1.10B
1W Leistung:
+1.85%
1M Leistung:
+3.17%
6M Leistung:
+6.16%
1J Leistung:
+18.30%
1-Tages-Spanne:
$128.49
$131.93
1-Wochen-Bereich:
$125.78
$131.93
52-Wochen-Spanne:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Vergleichen Sie JAZZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
131.80 | 7.83B | 3.99B | 463.16M | 1.10B | 7.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Eingeleitet | Deutsche Bank | Buy |
| 2025-03-07 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Will Jazz Pharmaceuticals plc stock rally after Fed decisionsRisk Management & Consistent Profit Alerts - newser.com
Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Jazz Pharmaceuticals plc stock keep outperforming rivalsBuy Signal & Fast Gain Swing Alerts - newser.com
What MACD and RSI say about Jazz Pharmaceuticals plcEarnings Performance Report & Weekly Sector Rotation Insights - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com
Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews
State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Why Jazz Pharmaceuticals plc (J7Z) stock could be top winner2025 Big Picture & AI Forecasted Stock Moves - newser.com
What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in
Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in
What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in
Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st
Is Jazz Pharmaceuticals plc a candidate for recovery playOptions Play & Weekly Chart Analysis and Guides - newser.com
Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN
What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener
JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus
Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
United States Myelodysplastic Syndrome Treatment Market - openPR.com
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN
Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News
Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail
Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance
Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK
Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st
Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN
Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com
Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider
Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire
United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com
Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat
Strs Ohio Purchases Shares of 16,445 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Lingohr Asset Management GmbH Sells 37,288 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):